Your browser doesn't support javascript.
loading
Phase I Study of P-cadherin-targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors.
Subbiah, Vivek; Erwin, William; Mawlawi, Osama; McCoy, Asa; Wages, David; Wheeler, Catherine; Gonzalez-Lepera, Carlos; Liu, Holly; Macapinlac, Homer; Meric-Bernstam, Funda; Hong, David S; Pant, Shubham; Le, Dao; Santos, Elmer; Gonzalez, Jose; Roszik, Jason; Suzuki, Takeaki; Subach, Ruth Ann; Madden, Timothy; Johansen, Mary; Nomura, Fumiko; Satoh, Hirokazu; Matsuura, Tadashi; Kajita, Masamichi; Nakamura, Eri; Funase, Yuichi; Matsushima, Satoshi; Ravizzini, Gregory.
Afiliación
  • Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. VSubbiah@mdanderson.org.
  • Erwin W; Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mawlawi O; Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • McCoy A; Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wages D; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts.
  • Wheeler C; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts.
  • Gonzalez-Lepera C; Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liu H; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Macapinlac H; Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Meric-Bernstam F; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hong DS; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pant S; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Le D; Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Santos E; Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gonzalez J; Department of Imaging Physics, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Roszik J; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Suzuki T; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts.
  • Subach RA; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts.
  • Madden T; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts.
  • Johansen M; FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts.
  • Nomura F; Perseus Proteomics, Inc., Tokyo, Japan.
  • Satoh H; Perseus Proteomics, Inc., Tokyo, Japan.
  • Matsuura T; Perseus Proteomics, Inc., Tokyo, Japan.
  • Kajita M; FUJIFILM Toyama Chemical Co., Ltd., Chiba, Japan.
  • Nakamura E; FUJIFILM Toyama Chemical Co., Ltd., Chiba, Japan.
  • Funase Y; FUJIFILM Toyama Chemical Co., Ltd., Chiba, Japan.
  • Matsushima S; FUJIFILM Toyama Chemical Co., Ltd., Chiba, Japan.
  • Ravizzini G; Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 26(22): 5830-5842, 2020 11 15.
Article en En | MEDLINE | ID: mdl-32816889
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cadherinas / Radioinmunoterapia / Anticuerpos Monoclonales / Neoplasias Límite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cadherinas / Radioinmunoterapia / Anticuerpos Monoclonales / Neoplasias Límite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos